The University of California, Los Angeles is a public land-grant research university in Los Angeles, California. UCLA’s academic roots were established in 1882 as a teachers college then known as the southern branch of the California State Normal School.

During the past decade, University of California, Los Angeles conducted 746 clinical trials. In the 10-year time frame, 746 clinical trials started and 312 clinical trials were completed, i.e. on average, 41.8% percent of trials that started reached the finish line to date. In the past 5 years, 347 clinical trials started and 174 clinical trials were completed. i.e. 50.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California, Los Angeles" #1 sponsor was "University of California, Los Angeles" with 276 trials, followed by "Jonsson Comprehensive Cancer Center" with 36 trials sponsored, "Novartis Pharmaceuticals" with 29 trials sponsored, "Hoffmann-La Roche" with 18 trials sponsored and "National Cancer Institute (NCI)" with 18 trials sponsored. Other sponsors include 852 different institutions and companies that sponsored additional 467 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, Los Angeles" #1 collaborator was "University of California, Los Angeles" with 81 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 32 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 31 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 31 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 30 trials as a collaborator. Other collaborators include 1075 different institutions and companies that were collaborators in the rest 525 trials.

According to Clinical.Site data, the most researched conditions in "University of California, Los Angeles" are "Prostate Cancer" (30 trials), "Breast Cancer" (28 trials), "Melanoma" (22 trials), "Schizophrenia" (17 trials) and "Depression" (15 trials). Many other conditions were trialed in "University of California, Los Angeles" in a lesser frequency.

Most popular intervention types in "University of California, Los Angeles" are "Drug" (674 trials), "Behavioral" (154 trials), "Device" (143 trials), "Other" (125 trials) and "Biological" (109 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (157 trials), "Pembrolizumab" (25 trials), "Bevacizumab" (16 trials), "placebo" (16 trials) and "Atezolizumab" (15 trials). Other intervention names were less common.

The vast majority of trials in "University of California, Los Angeles" are 1087 trials for "All" genders, 77 trials for "Female" genders and 65 trials for "Male" genders.

Currently, there are 434 active trials in "University of California, Los Angeles". 11 are not yet recruiting, 257 are recruiting, 144 are Active, not recruiting, and 22 are Enrolling by invitation. In total, there were 589 completed trials in University of California, Los Angeles, 6 suspended trials, and 134 terminated clinical trials to date.

Out of the total trials that were conducted in University of California, Los Angeles, 219 "Phase 1" clinical trials were conducted, 398 "Phase 2" clinical trials and 228 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 278 trials that are defined as “Not Applicable".

University of California, Los Angeles has several departments that took part in Clinical trials: "Jonsson Comprehensive Cancer Center, UCLA" - 725 trials, "UCLA School of Dentistry" - 8 trials, "UCLA Department of Psychology" - 7 trials, "UCLA School of Nursing" - 6 trials, "UCLA - JCCC Clinical Research Unit" - 6 trials, "Division Of Hematology & Oncology Ctr. For Health Sciences" - 6 trials, "UCLA Department of Psychiatry and Biobehavioral Sciences" - 4 trials, "UCLA Center for Cancer Prevention & Control Research" - 3 trials, "UCLA Depression Research and Clinic Program" - 3 trials, "UCLA Semel Institute - Neuropsychiatric Institute (NPI)" - 3 trials, "UCLA Community Oncology Practice" - 2 trials, "Jeffrey Wood" - 2 trials, "UCLA CTRC Outpatient Unit" - 2 trials, "UCLA Hematology/Oncology - Administrative Office" - 2 trials, "UCLA Child and Adolescent Mood Disorders Program, UCLA School of Medicine" - 2 trials